Search

Your search keyword '"Cicero, Afg"' showing total 511 results

Search Constraints

Start Over You searched for: Author "Cicero, Afg" Remove constraint Author: "Cicero, Afg"
511 results on '"Cicero, Afg"'

Search Results

1. Self-Reported Coffee Consumption and Central and Peripheral Blood Pressure in the Cohort of the Brisighella Heart Study

2. An evidence-based review on urate-lowering treatments: implications for optimal treatment of chronic hyperuricemia

3. Corrigendum to: High heart rate amplifies the risk of cardiovascular mortality associated with elevated uric acid

4. Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project

5. Retargeting the management of hypercholesterolemia – focus on evolocumab

6. Serum uric acid / serum creatinine ratio as a predictor of cardiovascular events. Detection of prognostic cardiovascular cut-off values

7. The importance of including uric acid in the definition of metabolic syndrome when assessing the mortality risk

8. Relationships between diuretic related hyperuricemia and cardiovascular events: data from the URRAH (URic acid Right for heArt Health) study

9. Cost-effectiveness of zofenopril in patients with left ventricular systolic dysfunction after acute myocardial infarction: a post hoc analysis of SMILE-4

10. Association of types of dietary fats and all-cause and cause-specific mortality: A prospective cohort study and meta-analysis of prospective

11. Effect of Dietary Insulinemia on All-Cause and Cause-Specific Mortality

12. Serum uric acid and fatal myocardial infarction: Detection of prognostic cut-off values: The URRAH (Uric Acid Right for Heart Health) study

13. Tomato and Lycopene Consumption Is Inversely Associated with Total and Cause-Specific Mortality

14. Nutraceuticals and blood pressure control: A European Society of Hypertension position document

15. Protective role of nutraceuticals against myocarditis

16. Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990-2050

17. Why patients with familial hypercholesterolemia are at high cardiovascular risk? Beyond LDL-C levels

18. Interaction between low-density lipoprotein-cholesterolaemia, serum uric level and incident hypertension: data from the Brisighella Heart Study

19. Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group. Vitamin D supplementation and incident preeclampsia: A systematic review and meta-analysis of randomized clinical trials

22. Associations of serum uric acid with total and cause-specific mortality: Findings from individuals and pooling prospective studies

23. Exploration into Uric and Cardiovascular Disease: Uric Acid Right for heArt Health (URRAH) Project, A Study Protocol for a Retrospective Observational Study

24. Cardiovascular Risk Reduction with Icosapent Ethyl

25. Nutraceuticals and Hypertensive Disorders in Pregnancy: The Available Clinical Evidence

26. Intossicazione, dipendenze, avvelenamenti

27. Effetto di un nutraceutico combinato su sintomi menopausali e fattori di rischio cardiometabolici in donne dislipidemiche affette da sindrome perimenopausale

28. Esteri etilici degli acidi grassi polinsaturi della serie omega 3: dalla biochimica alle crescenti potenzialità cliniche

30. 40(th) EASD Annual Meeting of the European Association for the Study of Diabetes : Munich, Germany, 5-9 September 2004

40. Effects of Rosiglitazone and Pioglitazone Combined with Metformin on the Prothrombotic State of Patients with Type 2 Diabetes Mellitus and Metabolic Syndrome

46. Case Problem

47. Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial [corrected] [published erratum appears in CLIN THER 2006 Sep;28(9):1483].

48. Effects of a new low dose soy protein/ß-sitosterol association on plasma lipid levels and oxidation.

49. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.

50. Comparison of the effects of telmisartan and nifedipine gastrointestinal therapeutic system on blood pressure control, glucose metabolism, and the lipid profile in patients with type 2 diabetes mellitus and mild hypertension: a 12-month, randomized, double-blind study.

Catalog

Books, media, physical & digital resources